# Pharmacokinetics of Mmf and Valganciclovir

> **NCT00189150** · PHASE4 · COMPLETED · sponsor: **University of Michigan** · enrollment: 16 (actual)

## Conditions studied

- Kidney Transplant Recipient
- Heart Transplant Recipient

## Interventions

- **DRUG:** Mycophenolate mofetil
- **DRUG:** Valganciclovir

## Key facts

- **NCT ID:** NCT00189150
- **Lead sponsor:** University of Michigan
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-04
- **Primary completion:** 2007-08
- **Final completion:** 2007-08
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2016-05-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00189150

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00189150, "Pharmacokinetics of Mmf and Valganciclovir". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00189150. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*